Radiofrequency Neurolysis denials in California external review

In the California DMHC record, independent physician reviewers decided 51 published external-review cases involving Radiofrequency Neurolysisand overturned the plan’s denial in 33.3%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
51
2009–2025
Overturned
33.3%
17 denials reversed

Conditions behind Radiofrequency Neurolysis denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Sacroiliac Joint Pain5
0%
Low Back Pain4
50%
Sacroiliac Joint Dysfunction3
33.3%
Lumbar Radiculopathy3
0%
Sacroiliitis3
0%
Typical time to a decision
19 days
Most land between 13 and 21 days
Handled as urgent
11.8%
Expedited when a delay would cause harm
Recent direction
Rising
19%36.4% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested radiofrequency neurolysis for treatment of the enrollee’s mid and lower back pain. Findings: Two physician reviewers found that the request for radiofrequency neurolysis is likely to be more beneficial for treatment of the patient’s medical condition than any available standard therapy. There is medical literature supporting the utility of thoracic facet radiofrequency neurolysis for the treatment of pain due to thoracic facet pain. Hegarty performed a 12-month retrospective observational evaluation of adults treated with radiofrequency (RF) for refractory sacroiliac joint syndrome (SIJ).
Experimental/Investigational · 2016 · IMR EI16-23718
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for radiofrequency neurolysis/ablation. Review of the literature with comprehensive analysis of the published data pertaining to the effectiveness and risks of fluoroscopically guided cervical medial branch thermal radiofrequency neurotomy for treating chronic neck pain of zygoapophyseal joint origin. The authors concluded that if performed as described in the International Spine Intervention Society guidelines, fluoroscopically guided cervical medial branch thermal radiofrequency neurotomy is effective for cervical zygoapophyseal joint pain and carries only minor risks. This patient complains primarily of severe left-sided neck pain with radiation to the shoulders and head. The provider does not document any evidence of radiculopathy.
Experimental/Investigational · 2018 · IMR EI18-28870

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for radiofrequency neurolysis for treatment of the enrollee’s recurrent back pain. Findings: Two physician reviewers found that the patient was status post L4/5 microdiscectomy. The treating provider’s report indicated that the patient received one week of pain relief following the caudal and left L5 transforaminal epidural steroid injections. She reported that she also had pain on the right and left lumbar areas with burning and shooting pain down her legs. She felt like her back and legs were going to give out. A lumbar spine examination documented normal alignment and no tenderness to palpation. Range of motion was documented as flexion 90 degrees, extension 15 degrees, and negative straight leg raise at 70 degrees. Lower extremity neurologic examination was reported within normal limits.
Experimental/Investigational · 2016 · IMR EI16-24321
A 48-year-old female enrollee has requested authorization and coverage for radiofrequency neurolysis for treatment of the enrollee’s chronic pain. Findings: Two physician reviewers found that the patient has chronic low back pain. She is status post posterior lumbar fusion at L4-5 and intrathecal pump placement for chronic low back pain. The patient’s medications include oxycodone, Baclofen, and intrathecal bupivacaine. Sacroiliac joint injections were performed, which reportedly resulted in more than 50% reduction in her pain.
Experimental/Investigational · 2012 · IMR EI12-14179

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Radiofrequency Neurolysis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Radiofrequency Neurolysis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39